Phase II study of FOLFIRI regimen in patients with advanced colorectal cancer refractory to fluoropyrimidine and oxaliplatin

Cancer Chemotherapy and Pharmacology

Volumn 67, Issue 1, 2011, Pages 147-152

  Bao, Han Ying ^a   Fang, Wei Jia ^a   Zhang, Xiao Chen ^a   Shi, Gen Ming ^a   Huang, Sui ^a   Yu, Lan Fang ^a   Chen, Jin ^a   Mou, Hai Bo ^a   Deng, Jing ^a   Shen, Peng ^a   Xu, Nong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

FOLFIRI; Irinotecan; Metastatic colorectal cancer; Second line chemotherapy

Indexed keywords

FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CHINESE; COLORECTAL CANCER; CONSTIPATION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SIDE EFFECT; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CHINA; COLORECTAL NEOPLASMS; DIARRHEA; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NAUSEA; NEUTROPENIA; ORGANOPLATINUM COMPOUNDS; PYRIMIDINES; SURVIVAL; VOMITING; YOUNG ADULT;

EID: 78651062850     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-010-1301-5     Document Type: Article

References (19)

1. A Jemal A Thomas T Murray, et al. 2002 Cancer statistics CA Cancer J Clin 52 23 47 10.3322/canjclin.52.1.23 11814064
2. Yang Ling Li Liandi CAen Yude, et al. 2005 Cancer incidence and mortality estimates and prediction for year 2000 an d 2005 in China Chin J Health Stat 22 218 221
3. A de Gramont A Figer M Seymour, et al. 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938 2947 10944126
4. JY Douillard D Cunningham AD Roth, et al. 2000 Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 1041 1047 1:CAS:528:DC%2BD3cXisFOnsb4%3D 10.1016/S0140-6736(00)02034-1 10744089
5. RM Goldberg DJ Sargent RF Morton, et al. 2004 A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 23 30 1:CAS:528:DC%2BD2cXpsVKitbY%3D 10.1200/JCO.2004.09.046 14665611 (Pubitemid 41095110)
6. LB Saltz JV Cox C Blanke, et al. 2000 Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan study group N Engl J Med 343 905 914 1:CAS:528:DC%2BD3cXntFOkt7Y%3D 10.1056/NEJM200009283431302 11006366
7. H Hurwitz L Fehrenbacher W Novotny, et al. 2004 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2335 2342 1:CAS:528:DC%2BD2cXks1Gjt74%3D 10.1056/NEJMoa032691 15175435 (Pubitemid 38702844)
8. D Cunningham S Pyrhonen RD James, et al. 1998 Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer Lancet 352 1413 1418 1:CAS:528:DyaK1cXnsVSmsLs%3D 10.1016/S0140-6736(98)02309-5 9807987 (Pubitemid 28510874)
9. P Rougier E Van Cutsem E Bajetta, et al. 1998 Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer Lancet 352 1407 1412 1:CAS:528:DyaK1cXnsVSmsLo%3D 10.1016/S0140-6736(98)03085-2 9807986 (Pubitemid 28510873)
10. C Tournigand T Andre E Achille, et al. 2004 FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 229 237 1:CAS:528:DC%2BD2cXpsVKit7w%3D 10.1200/JCO.2004.05.113 14657227 (Pubitemid 41095086)
11. AF Sobrero J Maurel L Fehrenbacher, et al. 2008 EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer J Clin Oncol 26 2311 2319 1:CAS:528:DC%2BD1cXntVOltrk%3D 10.1200/JCO.2007.13.1193 18390971
12. Advanced Colorectal Cancer Meta-Analysis Project 1992 Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer. Evidence in terms of response rate J Clin Oncol 10 896 903
13. A de Gramont JF Bosset C Milan, et al. 1997 Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study J Clin Oncol 15 808 815 9053508
14. CS Fuchs J Marshall E Mitchell, et al. 2007 Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C study J Clin Oncol 25 4779 4786 1:CAS:528:DC%2BD2sXhtlCgsLbM 10.1200/JCO.2007.11.3357 17947725 (Pubitemid 350086481)
15. G Folprecht MT Seymour L Saltz, et al. 2008 Irinotecan/Fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2, 691 patients in randomized controlled trials J Clin Oncol 26 1443 1451 1:CAS:528:DC%2BD1cXkslKqsLw%3D 10.1200/JCO.2007.14.0509 18349394
16. M Mabro P Artru T Andre, et al. 2006 A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients Br J Cancer 94 1287 1292 1:CAS:528: DC%2BD28XktVaht7k%3D 10.1038/sj.bjc.6603095 16622455
17. Y Wang JM Xu L Shen, et al. 2007 Polymorphisms of UGT1A gene and irinotecan toxicity in Chinese colorectal cancer patients Zhonghua Zhong Liu Za Zhi 29 913 916 1:CAS:528:DC%2BD1cXjsVCis7Y%3D 18478930
18. P Canal C Gay A Dezeuze, et al. 1996 Pharmacokinetics and pharmacodynamics of irinotecan during a phase II clinical trial in colorectal cancer J Clin Oncol 14 2688 2695 1:CAS:528:DyaK28XmsFCgtrk%3D 8874328
19. FC Bidard C Tournigand T André 2009 Efficacy of FOLFIRI-3 (irinotecan D1, D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study Ann Oncol 20 1042 1047 10.1093/annonc/mdn730 19153116